Advertisement

Topics

Barrington Research Lowers Pharmerica Corporation (PMC) to Underperform

08:13 EDT 9 Aug 2017 | Topix

Barrington Research also issued estimates for Pharmerica Corporation's Q4 2018 earnings at $0.59 EPS. A number of other research analysts have also weighed in on PMC.

Original Article: Barrington Research Lowers Pharmerica Corporation (PMC) to Underperform

NEXT ARTICLE

More From BioPortfolio on "Barrington Research Lowers Pharmerica Corporation (PMC) to Underperform"

Quick Search
Advertisement